Physician profile
Judith Bedoy
NPI 1396831145
$2,047.15
in general payments reported to CMS, 2019-2025
13 companies · $200 in 2025
The $200 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $194 · 2020: $302 · 2021: $332 · 2022: $287 · 2023: $294 · 2024: $438 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $932.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $931.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $404.88 | 2019-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Cranial Technologies, INC | $356.46 | 2019-2025 | Doc Band |
| Pfizer INC. | $318.60 | 2019-2025 | |
| Glaxosmithkline, LLC. | $292.75 | 2019-2025 | Bexsero |
| Sanofi Pasteur INC. | $251.84 | 2019-2025 | |
| Phadia US INC. | $108.20 | 2019-2023 | Immunocap |
| Verrica Pharmaceuticals INC. | $92.12 | 2024 | Ycanth |
| Alk-Abello, INC | $63.95 | 2023-2024 | Odactra, Grastek, Ragwitek |
| Sobi, INC | $60.83 | 2022-2024 | |
| Seqirus USA INC | $47.53 | 2025 | Flucelvax, Fluad |
| Ultragenyx Pharmaceutical INC. | $23.42 | 2022 | |
| Hologic Sales and Service, LLC | $19.39 | 2023 | Thinprep 2000 Processor, Aptima |
| Organon LLC | $7.18 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judith Bedoy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.